Skip to content

Healthcare companies and projects

Explore healthcare companies and projects across pharmaceuticals, biotechnology, medical equipment, care services and health-data infrastructure. Browse public profiles and the evaluations available on Orbitrum, then discover the experts behind the research.

Projects in Healthcare

1,179 projects

Ascentage PharmaAscentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company’s primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL proteins for the treatment of small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumor, and non-Hodgkin’s lymphoma. In addition, the company is developing APG-1387, a small-molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection; APG-5918, an orally available and selective embryonic ectoderm development inhibitor. In addition, it is involved in medical research and development; clinical development; clinical trials operations; venture capital investment; rental of buildings; and provision of science and technology promotion services. The company has collaboration relationships with biotechnology and pharmaceutical companies; and research institutions. Ascentage Pharma Group International was founded in 2009 and is headquartered in Suzhou, China.Web2
ATAI BeckleyAtaiBeckley Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial for cognitive impairment associated with schizophrenia; and ELE-101, a serotonergic psychedelic for the treatment of major depressive disorder. It is also developing VLS-01, an oral transmucosal film formulation of N,N-Dimethyltryptamine in Phase 2 clinical study to treat TRD; EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine that is in Phase 2 clinical study for social anxiety disorder; and EGX-A & EGX-B, which are non-hallucinogenic 5-HT2A receptor agonists for TRD. In addition, the company offers COMP360 for psilocybin therapy; and GRX-917 for the treatment of anxiety, depression, and various neurological disorders. The company was formerly known as Atai Beckley N.V. and changed its name to AtaiBeckley Inc. in December 2025. AtaiBeckley Inc. was founded in 2018 and is based in New York, New York.Web2

About this sector

Healthcare includes both medical businesses and projects supporting how health information or research is managed. Its application sub-sectors cover pharmaceuticals, biotechnology and medical research, healthcare equipment and providers, medical records, research transparency, supply-chain transparency and patient-data privacy.

How to compare projects

A drug developer, a device supplier, a care provider and a health-data project have different activities. Use the sub-sector to establish that context, then read the actual evaluation rather than assuming a score describes every aspect of the business. This collection is for project research, not for choosing a medical treatment.

Projects follow the categories assigned in the Orbitrum application. This collection supports research and discovery; it is not an investment ranking.

Industry definitions

Healthcare Equipment & Supplies (1,090)

Suppliers of healthcare equipment and related supplies.

Pharmaceuticals (1,515)

Companies classified specifically in pharmaceuticals.

Biotechnology & Medical Research (1,179)

Companies and projects focused on biotechnology or medical research.

Healthcare Providers & Services (573)

Organizations providing healthcare or related services.

Questions to guide your research

  • What product, service or health-data function does the project provide?
  • Which development or operating milestones are documented in the profile and research?
  • What evidence and limitations does the author discuss?

Questions about this sector

Does this sector include biotechnology and medical devices?

Yes. The current application classification includes biotechnology and medical research, pharmaceuticals, healthcare equipment and supplies, and healthcare services and medical devices. The list below reflects the categories available in Orbitrum.

How can I find healthcare experts?

Open the authors attached to published evaluations or analysis of these projects. Their profiles show the work available on Orbitrum; a project category alone does not establish an author's medical qualifications.

Relevant research

Authors covering these projects

Explore related sectors